These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30714579)

  • 1. EULAR 'points to consider' for the conduction of workforce requirement studies in rheumatology.
    Dejaco C; Putrik P; Unger J; Aletaha D; Bianchi G; Bijlsma JW; Boonen A; Cikes N; Finckh A; Gossec L; Kvien TK; Madruga Dias J; Matteson EL; Sivera F; Stamm TA; Szekanecz Z; Wiek D; Zink A; Ramiro S; Buttgereit F
    RMD Open; 2018; 4(2):e000780. PubMed ID: 30714579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider.
    Unger J; Putrik P; Buttgereit F; Aletaha D; Bianchi G; Bijlsma JWJ; Boonen A; Cikes N; Dias JM; Falzon L; Finckh A; Gossec L; Kvien TK; Matteson EL; Sivera F; Stamm TA; Szekanecz Z; Wiek D; Zink A; Dejaco C; Ramiro S
    RMD Open; 2018; 4(2):e000756. PubMed ID: 30714580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 EULAR points to consider for the assessment of competences in rheumatology specialty training.
    Sivera F; Alunno A; Najm A; Avcin T; Baraliakos X; Bijlsma JW; Badreh S; Burmester G; Cikes N; Da Silva JA; Damjanov N; Dougados M; Dudler J; Edwards CJ; Iagnocco A; Lioté F; Nikiphorou E; van Onna M; Stones SR; Vassilopoulos D; Haines C; Ramiro S
    Ann Rheum Dis; 2021 Jan; 80(1):65-70. PubMed ID: 32788400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs).
    Dejaco C; Machado PM; Carubbi F; Bosch P; Terslev L; Tamborrini G; Sconfienza LM; Scirè CA; Ruetten S; van Rompay J; Proft F; Pitzalis C; Obradov M; Moe RH; Mascarenhas VV; Malattia C; Klauser AS; Kent A; Jans L; Hartung W; Hammer HB; Duftner C; Balint PV; Alunno A; Baraliakos X
    Ann Rheum Dis; 2022 Jun; 81(6):760-767. PubMed ID: 34893469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis.
    Boonen A; Putrik P; Marques ML; Alunno A; Abasolo L; Beaton D; Betteridge N; Bjørk M; Boers M; Boteva B; Fautrel B; Guillemin F; Mateus EF; Nikiphorou E; Péntek M; Pimentel Santos F; Severens JL; Verstappen SMM; Walker-Bone K; Wallman JK; Ter Wee MM; Westhovens R; Ramiro S
    Ann Rheum Dis; 2021 Sep; 80(9):1116-1123. PubMed ID: 33832966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology.
    Courvoisier DS; Lauper K; Kedra J; de Wit M; Fautrel B; Frisell T; Hyrich KL; Iannone F; Machado PM; Ørnbjerg LM; Rotar Z; Santos MJ; Stamm TA; Stones SR; Strangfeld A; Bergstra SA; Landewé RBM; Finckh A
    Ann Rheum Dis; 2022 Jun; 81(6):780-785. PubMed ID: 35058229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.
    Mankia K; Siddle HJ; Kerschbaumer A; Alpizar Rodriguez D; Catrina AI; Cañete JD; Cope AP; Daien CI; Deane KD; El Gabalawy H; Finckh A; Holers VM; Koloumas M; Ometto F; Raza K; Zabalan C; van der Helm-van Mil A; van Schaardenburg D; Aletaha D; Emery P
    Ann Rheum Dis; 2021 Oct; 80(10):1286-1298. PubMed ID: 34362746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.
    Najm A; Nikiphorou E; Kostine M; Richez C; Pauling JD; Finckh A; Ritschl V; Prior Y; Balážová P; Stones S; Szekanecz Z; Iagnocco A; Ramiro S; Sivera F; Dougados M; Carmona L; Burmester G; Wiek D; Gossec L; Berenbaum F
    RMD Open; 2019; 5(2):e001014. PubMed ID: 31565245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR points to consider for the use of big data in rheumatic and musculoskeletal diseases.
    Gossec L; Kedra J; Servy H; Pandit A; Stones S; Berenbaum F; Finckh A; Baraliakos X; Stamm TA; Gomez-Cabrero D; Pristipino C; Choquet R; Burmester GR; Radstake TRDJ
    Ann Rheum Dis; 2020 Jan; 79(1):69-76. PubMed ID: 31229952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
    Rodríguez-Carrio J; Burska A; Conaghan PG; Dik WA; Biesen R; Eloranta ML; Cavalli G; Visser M; Boumpas DT; Bertsias G; Wahren-Herlenius M; Rehwinkel J; Frémond ML; Crow MK; Rönnblom L; Versnel MA; Vital EM
    Ann Rheum Dis; 2023 Jun; 82(6):754-762. PubMed ID: 36858821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis.
    Bech B; Primdahl J; van Tubergen A; Voshaar M; Zangi HA; Barbosa L; Boström C; Boteva B; Carubbi F; Fayet F; Ferreira RJO; Hoeper K; Kocher A; Kukkurainen ML; Lion V; Minnock P; Moretti A; Ndosi M; Pavic Nikolic M; Schirmer M; Smucrova H; de la Torre-Aboki J; Waite-Jones J; van Eijk-Hustings Y
    Ann Rheum Dis; 2020 Jan; 79(1):61-68. PubMed ID: 31300458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatology Workforce Planning in Western Countries: A Systematic Literature Review.
    Dejaco C; Lackner A; Buttgereit F; Matteson EL; Narath M; Sprenger M
    Arthritis Care Res (Hoboken); 2016 Dec; 68(12):1874-1882. PubMed ID: 27015436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.
    Dejaco C; Ramiro S; Duftner C; Besson FL; Bley TA; Blockmans D; Brouwer E; Cimmino MA; Clark E; Dasgupta B; Diamantopoulos AP; Direskeneli H; Iagnocco A; Klink T; Neill L; Ponte C; Salvarani C; Slart RHJA; Whitlock M; Schmidt WA
    Ann Rheum Dis; 2018 May; 77(5):636-643. PubMed ID: 29358285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Points to consider: EULAR-UEMS standards for the training of European rheumatologists.
    Alunno A; Avcin T; Haines C; Ramiro S; Sivera F; Badreh S; Baraliakos X; Bijlsma JWJ; Buttgereit F; Chaudhuri K; Da Silva JAP; Dudler J; Ferreira RJO; Gudu T; Hachulla E; Holland-Fischer M; Iagnocco A; Kragstrup TW; Nagy G; Romão VC; Stones SR; van Onna M; Edwards CJ
    Ann Rheum Dis; 2023 Aug; 82(8):1107-1113. PubMed ID: 37188497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases.
    de Thurah A; Bosch P; Marques A; Meissner Y; Mukhtyar CB; Knitza J; Najm A; Østerås N; Pelle T; Knudsen LR; Šmucrová H; Berenbaum F; Jani M; Geenen R; Krusche M; Pchelnikova P; de Souza S; Badreh S; Wiek D; Piantoni S; Gwinnutt JM; Duftner C; Canhão HM; Quartuccio L; Stoilov N; Prior Y; Bijlsma JW; Zabotti A; Stamm TA; Dejaco C
    Ann Rheum Dis; 2022 Aug; 81(8):1065-1071. PubMed ID: 35470160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
    Boonen A; Webers C; Butink M; Barten B; Betteridge N; Black DC; Bremander A; Boteva B; Brzezińska O; Chauhan L; Copsey S; Guimarães V; Gignac M; Glaysher J; Green F; Hoving JL; Marques ML; Smucrova H; Stamm TA; Wiek D; Wilkie R; Woolf AD; Burmester GR; Bijlsma JW; Verstappen SMM
    Ann Rheum Dis; 2023 Jan; 82(1):57-64. PubMed ID: 36109139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of synovial biopsy procedures and disease-specific aspects on synovial tissue outcome: a systematic literature review informing the EULAR points to consider for the minimal reporting requirements in synovial tissue research in rheumatology.
    Najm A; Costantino F; Weill C; Filer A; D'Agostino MA
    RMD Open; 2022 Feb; 8(1):. PubMed ID: 35177556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The United States rheumatology workforce: supply and demand, 2005-2025.
    Deal CL; Hooker R; Harrington T; Birnbaum N; Hogan P; Bouchery E; Klein-Gitelman M; Barr W
    Arthritis Rheum; 2007 Mar; 56(3):722-9. PubMed ID: 17328042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric rheumatology consultant workforce in Australia and New Zealand: the current state of play and challenges for the future.
    Cox A; Piper S; Singh-Grewal D
    Int J Rheum Dis; 2017 May; 20(5):647-653. PubMed ID: 26864133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
    Kostine M; Finckh A; Bingham CO; Visser K; Leipe J; Schulze-Koops H; Choy EH; Benesova K; Radstake TRDJ; Cope AP; Lambotte O; Gottenberg JE; Allenbach Y; Visser M; Rusthoven C; Thomasen L; Jamal S; Marabelle A; Larkin J; Haanen JBAG; Calabrese LH; Mariette X; Schaeverbeke T
    Ann Rheum Dis; 2021 Jan; 80(1):36-48. PubMed ID: 32327425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.